Abstract:Objective: This article focused on the synthesis and characterization of heterocyclic compounds containing two heteroatoms, as well as computational investigations, the acetylcholinesterase enzyme assay, and antioxidant properties. Methods: in this article, we conducted multicomponent reactions and these reactions were based on the condensation method. The DPPH method was used to determine antioxidant activity results. Results: The present study includes the synthesis of 3-{[(1-H-benzimidazole-2-yl)sulfanyl](heterocarbaldehyde)methyl}4-hydroxy-2- H -benzopyran-2-one derivatives by the one-pot multicomponent reaction and further structures were characterized by various analytical techniques. Discussion: Design and synthesis of coumarin derivatives and confirmed by different spectroscopic techniques DFT calculations at B3YLP/6-311+G(d,p) were used to perform geometry optimization on the coumarin derivatives. MEP provides a visual method for understanding a molecule's reactivity. In Acetylcholinesterase inhibitory assay, the HeLa cell line is treated with synthesized compounds and compounds show promising activity. Additionally, the 3D representation of all derivatives' interactions with proteins and ligands as well as the active site of ligands on receptor surfaces. Conclusions: A novel series of coumarinbenzimidazole compounds was successfully developed and synthesized. Among all, compound ( IVa ) demonstrates good inhibition against Hela cancer cell lines, which is corroborated by in silico docking studies in which ( IVa ) compound has a good binding affinity of –10.1 kcl/mol, indicating the best binding interactions with the receptor when compared to the target molecules.

Studies on Bio-rational design of photosystem II inhibitors ( III ) - Comparative molecular field analysis of 3-(4-chlorobenzylamino)-2-cyano-3-alkylacryl ate inhibitors

Studies on bio-rational design of photosystem II inhibitors (III) - Comparative molecular field analysis of 3-(4-chlorobenzylamino)-2-cyano-3-alkylacrylate inhibitors

Studies on bio-rational design of photosystem II inhibitors ( II ) - The crystal and molecular structure of ethyl 3-benzylamino-2-cyano-3-methylthioacrylate

Studies on bio-rational design of photosystem II inhibitors ( V ) - Synthesis and hill inhibitory activities of ethyl arylamideacrylates and pyrimidone

Bio-rational Design of Photosystem II Inhibitors (VIII)

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Biorational design, synthesis, and inhibition of photosystem II inhibitors

Binding Model And 3d-Qsar Of 3-(2-Chloropyrid-5-Ylmethylamino)-2-Cyanoacrylates As Psii Electron Transport Inhibitor

Bio-Rational Design Synthesis of Novel Herbicides

3D-QSAR Studies on AChE Inhibitory Activities of 2-Phenoxy-indan-1-one Derivatives

Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers.

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

Molecular Simulation Studies of Interactions Between Ketol-Acid Reductoisomerase and Its Inhibitors

Studies on the 3D-Qsar of Novel 1-Aryl-1, 4-Dihydro-3-acylhydrazinocarbonyl-6-methyl-4-pyridazinones

Molecular docking and molecular dynamic simulations of inhibitor ZJ0777 and CIE binding to acetohydroxyacid synthases

Synthesis, Herbicidal Activities, and 3D-Qsar of 2-Cyanoacrylates Containing Aromatic Methylamine Moieties

Acetylcholine Inhibitory Study of Novel Thio Linked Coumarin-Benzimidazole Derivatives: Design, Synthesis, Computational, and In Silico Molecular Docking Studies

3D-QSAR Studies on 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors by Comparative Molecular Field Analysis (Comfa)

Synthesis of Novel Derivatives of 2-Cyano-3-methylthio-3 '-Benzylamino Acrylates(Acrylamides) and Their Biological Activity

Design, Synthesis, and Analysis of the Quantitative Structure-Activity Relationships of 4-Phenyl-acyl-substituted 3-(2,5-dimethylphenyl)-4-hydroxy-1-azaspiro[4.5]dec-3-ene-2,8-dione Derivatives